Bausch Health Companies Statistics

Total Valuation

Bausch Health Companies has a market cap or net worth of CAD 3.95 billion. The enterprise value is 35.17 billion.

Market Cap	3.95B
Enterprise Value	35.17B

Important Dates

The next estimated earnings date is Thursday, February 20, 2025.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.90%
Shares Change (QoQ)	-0.49%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	273.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.77, with an EV/FCF ratio of 24.63.

EV / Earnings	-146.24
EV / Sales	2.58
EV / EBITDA	7.77
EV / EBIT	13.75
EV / FCF	24.63

Financial Position

The company has a current ratio of 1.19

Current Ratio	1.19
Quick Ratio	0.62
Debt / Equity	n/a
Debt / EBITDA	6.83
Debt / FCF	20.35
Interest Coverage	1.26

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	4.15%
Return on Capital (ROIC)	5.12%
Revenue Per Employee	631,421
Profits Per Employee	-11,863
Employee Count	20,270
Asset Turnover	0.35
Inventory Turnover	1.89

Taxes

In the past 12 months, Bausch Health Companies has paid 214.44 million in taxes.

Income Tax	214.44M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.36% in the last 52 weeks. The beta is 0.77, so Bausch Health Companies's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	+6.36%
50-Day Moving Average	11.67
200-Day Moving Average	10.47
Relative Strength Index (RSI)	41.16
Average Volume (20 Days)	340,583

Short Selling Information

The latest short interest is 2.83 million, so 0.78% of the outstanding shares have been sold short.

Short Interest	2.83M
Short Previous Month	2.17M
Short % of Shares Out	0.78%
Short % of Float	0.92%
Short Ratio (days to cover)	6.26

Income Statement

In the last 12 months, Bausch Health Companies had revenue of CAD 12.80 billion and -240.47 million in losses. Loss per share was -0.65.

Revenue	12.80B
Gross Profit	9.07B
Operating Income	2.40B
Pretax Income	-66.20M
Net Income	-240.47M
EBITDA	4.15B
EBIT	2.40B
Loss Per Share	-0.65

Full Income Statement

Balance Sheet

The company has 971.33 million in cash and 29.05 billion in debt, giving a net cash position of -28.08 billion.

Cash & Cash Equivalents	971.33M
Total Debt	29.05B
Net Cash	-28.08B
Net Cash Per Share	n/a
Equity (Book Value)	-326.93M
Book Value Per Share	-4.31
Working Capital	1.14B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.87 billion and capital expenditures -444.46 million, giving a free cash flow of 1.43 billion.

Operating Cash Flow	1.87B
Capital Expenditures	-444.46M
Free Cash Flow	1.43B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.87%, with operating and profit margins of 18.79% and -1.88%.

Gross Margin	70.87%
Operating Margin	18.79%
Pretax Margin	-0.52%
Profit Margin	-1.88%
EBITDA Margin	32.39%
EBIT Margin	18.79%
FCF Margin	11.16%

Dividends & Yields

Bausch Health Companies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.90%
Shareholder Yield	-0.90%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on October 5, 2000. It was a forward split with a ratio of 2.

Last Split Date	Oct 5, 2000
Split Type	Forward
Split Ratio	2

Scores

Bausch Health Companies has an Altman Z-Score of 0.16 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.16
Piotroski F-Score	3